PARTNERSHIP

ZeCardioTx has achieved several strategic partnerships, established over the past years by ZeClinics, to develop further cardiovascular novel therapies:


Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain

Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain Partnership to investigate several promising molecules, derived from natural plant sources, as potential best-in-class cardioprotectors.

University of Bern, Bern, Switzerland

University of Bern, Bern, Switzerland
Co-research agreement aimed at validating novel molecular targets involved in the regeneration of cardiac tissue, as potential future targets for new drugs favoring cardio-regeneration upon injury.

Longhua Hospital, Shanghai, China

Longhua Hospital, Shanghai, China
Obtained bilateral international funding (Spain-China) to test and develop a set of ancient Traditional Chinese Medicinal (TCM) plant extracts for their cardioprotective functions.

Taros Chemicals, Dortmund, Germany

Taros Chemicals, Dortmund, Germany
Co-development agreement aimed at improving our molecules with advanced and innovative chemistry-based technologies.